URINARY BIOMARKERS FOR CANCER DIAGNOSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20140323355A1
SERIAL NO

14265914

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to the field of cancer diagnosis, specifically to the diagnosis of bladder cancer (BC) and prostate cancer (CaP). More specifically, the invention provides simple, non-invasive urinary tests characterized by high sensitivity and specificity, wherein urinary levels of heat shock proteins and anti-inflammatory cytokines are used as biomarkers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
YEDA RESEARCH AND DEVELOPMENT CO LTDAT THE WEIZMANN INSTITUTE OF SCIENCE P O BOX 95 REHOVOT 7610002
MOR - RESEARCH APPLICATIONS LTD38 HABARZEL STREET TEL AVIV 69710

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BANIEL, Jack Ramat Gan, IL 4 38
COHEN, Irun R Rehovot, IL 113 1095
MARGEL, David Rehovot, IL 2 2
PEVSNER-FISCHER, Meirav Rehovot, IL 5 4
YOSSEPOWITCH, Ofer Ramat Hasharon, IL 15 370

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation